Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0XGNDR
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
C-met monoclonal antibody-drug conjugate
|
|||||
| Synonyms |
C-met monoclonal antibody-drug conjugate (Sorrento Therapeutics)
Click to Show/Hide
|
|||||
| Organization |
Sorrento Therapeutics, Inc.
|
|||||
| Drug Status |
Terminated
|
|||||
| Indication |
In total 1 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Terminated
|
|||||
| Antibody Name |
STI-D0606
|
Antibody Info | ||||
| Antigen Name |
Hepatocyte growth factor receptor (MET)
|
Antigen Info | ||||
| Payload Name |
Mertansine DM1
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.